C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
ACRHF Equity

Acreage Holdings

OTCMKTS · ACRHF

$0.00
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 3/5
40/100 composite
Fundamentals39
Regulatory49
Market40
Editorial30
Composite · trailing 12 months

Acreage Holdings earns a Neutral rating, supported by a 40.4 composite score and moderate 3/5 conviction. Regulatory is the strongest pillar at 49.0, driven by an 80.0 enforcement subscore and a 50.0 jurisdiction score, partly offset by a 25.0 filing-cadence score. Market contributes 40.0 despite the absence of an available quote, while fundamentals contribute 39.0 as gross profitability offsets contracting sales, negative EBITDA, and limited cash-runway support. Editorial contributes 30.0, reflecting no newsroom or brief activity. The resulting profile sits firmly in the Neutral band: regulatory standing provides the principal support, but weak commercial momentum and sparse disclosure prevent a more constructive rating.

Licensed fundamentals data show year-over-year revenue contracting 32.9%, the central drag on the 17.1 revenue-growth subscore. Gross margin remains comparatively strong at approximately 49.5%, producing an 82.5 gross-margin subscore, while the reported operating margin is flat and carries a 76.9 subscore. EBITDA remains negative at roughly $24.8 million, and the cash-burn ratio stands near 5.1; those readings restrain the fundamental pillar despite the stated stable financial condition. Market capitalization is approximately $4.9 million, corresponding with a zero market-cap tier contribution, while the cash-runway subscore is 15.0. Primary regulatory filings show no dated latest filing, no regulatory events across either the trailing 90-day or 180-day periods, and no enforcement hits. Institutional pricing feeds show no available quote, while CIN newsroom coverage records no recent newsroom or brief hits.

The clearest forward catalyst resides in regulatory disclosure rather than current operating performance. A renewed primary-filing cadence would directly address the weakest component inside the leading regulatory pillar, improve visibility into revenue stabilization and EBITDA progression, and provide a firmer basis for institutional pricing feeds and subsequent CIN newsroom coverage. With enforcement scoring already strong and jurisdiction posture holding at a midrange level, incremental regulatory documentation offers the most direct route to lifting the composite beyond Neutral. The single most important signal to watch is the appearance of a current primary regulatory filing that reestablishes cadence and updates operating performance.

Scored: 2026-09-23Valid through: 2026-11-07Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
Corporate DetailsCompany profile
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$4.9M
Enterprise value
$281.9M
Price to book
0.38
Price to sales
0.00
EV / EBITDA
-8.46
Revenue (TTM)
$193.6M
Gross profit (TTM)
$95.9M
EBITDA
$-24.8M
Operating margin
0.0%
Profit margin
0.0%
Rev growth YoY
-32.9%
Return on equity
-13558.8%
Return on assets
-6.4%
EPS (TTM)
$-0.85
Wall St. target price
$4.30
Shares outstanding
80.4M
Insider ownership
8.3%
Beta
1.99
Full-time employees
888
GICS sector
Healthcare
GICS industry
Drug Manufacturers - Specialty & Generic
Filings & DisclosuresPrimary sources
Filing portal
SEC EDGAR
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for Acreage Holdings (ACRHF)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Acreage Holdings (ACRHF), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for ACRHF are maintained by Cannabis Investor News and refreshed throughout the trading day.